Entity

Time filter

Source Type

La Jolla, CA, United States

Provided herein are PAK inhibitors and methods of utilizing PAK inhibitors for the treatment of CNS disorders such as neuropsychiatric disorders or neurofibromatosis. Also described herein are methods of utilizing PAK inhibitors for the treatment of cancer.


Patent
Afraxis Inc. | Date: 2012-11-02

Provided herein are PAK inhibitors and methods of utilizing PAK inhibitors for the treatment of Fragile X syndrome.


Patent
Afraxis Inc. | Date: 2014-08-14

Provided herein are PAK inhibitors. Also provided herein are compositions and methods for treating an individual suffering from schizophrenia


Provided herein are PAK inhibitors and methods of utilizing PAK inhibitors for the treatment of cell proliferative disorders and/or CNS disorders.


Patent
Afraxis Inc. | Date: 2014-04-30

Compounds having the formula I, or a pharmaceutically acceptable salt thereof, wherein R

Discover hidden collaborations